Picture of Memphasys logo

MEM — Memphasys Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Memphasys, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

C2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital1.881.531.331.120.904
Other Operating Cash Flow
Cash from Operating Activities-0.369-1.41-3.23-2.4-2.49
Capital Expenditures-2.24-1.82-0.638-0.82-0.003
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.155-0.155-0.073-0.0120
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-2.4-1.98-0.711-0.831-0.003
Financing Cash Flow Items-0.031-0.284-0.368-0.397-0.111
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.033.753.543.253.37
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.730.369-0.4030.0210.88